Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography.
about
"How many times must a man look up before he can really see the sky?" Rheumatic cardiovascular disease in the era of multimodality imaging.Libman-Sacks endocarditis and embolic cerebrovascular disease.APS and the brain.Current treatment of antiphospholipid syndrome: lights and shadows.Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's diseaseCardiovascular involvement in autoimmune diseases.Antiphospholipid syndrome; its implication in cardiovascular diseases: a review.Role of cardiovascular imaging in systemic autoimmune diseasesCardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report.Imaging assessment of cardiovascular disease in systemic lupus erythematosus.Haematology and neurology.Cardiac involvement in the antiphospholipid syndrome.Cardiac imaging techniques in systemic autoimmune diseases.Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.Antiphospholipid syndrome: A disease of protean face.Valvular heart disease in antiphospholipid syndrome.Underlying cause discovered for a prior idiopathic AMI.A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia.Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases.Atherosclerosis in primary antiphospholipid syndrome.Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
P2860
Q26785666-820D8095-265C-4787-AF47-934C72CE4C33Q30573314-6E57EEA2-AB27-4B3E-AE03-36F2B4A9CE5BQ33196667-610094F2-5CDD-4545-B951-F2495AC60EFFQ33423959-940D2131-9313-49E7-9265-B3A3CD45D4E3Q33937755-85A010A8-693A-4D66-AED1-C0D92C692B3EQ34081242-EF3EAD2F-D9C9-498C-B79A-D3FA94AFA64AQ34331685-06E06AE3-64EC-4DE0-A7CE-0E93D62675A0Q34390705-0CAFE786-EFF4-4C72-94CF-CC4C3F04B35CQ35189299-D22FE5E0-C6E8-409C-83B1-C6D8E908A709Q35450156-9B9F7480-A947-46CF-BFB1-64F0CE12385CQ36143295-74AADAAF-0945-4CBD-B1CF-59233BD070ABQ36283448-5166AA2C-A9B2-4AD5-8ECE-C491CB25C8DBQ36283477-EC719D28-85EE-4FEB-A87B-229E3A9348E6Q36596375-A988CD4B-5965-460D-AD7A-65FDC3D8792DQ37455173-124FE092-3779-4887-866B-6D2004187FF5Q38086166-77AE2ACD-5DBD-4825-8BC1-06FE48D2A60AQ42709881-72C3A1EC-5578-4BB4-BA4C-ADEEDEFA2CCBQ48016870-0C8F4A28-2071-4C55-B6B7-9FEF744162E1Q50355546-D4E81B98-2DDB-491F-B09F-1197565B56F2Q52852275-000E22B3-BC3F-4081-B681-66260DF666FFQ53159273-4D8849F2-B881-4237-A952-1A300B014AA7
P2860
Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@ast
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@en
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@nl
type
label
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@ast
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@en
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@nl
prefLabel
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@ast
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@en
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@nl
P2093
P2860
P1433
P1476
Evaluation of cardiac abnormal ...... nsesophageal echocardiography.
@en
P2093
P2860
P304
P356
10.1191/096120300678828532
P577
2000-01-01T00:00:00Z